Gender Therapy at a Crossroads

The Current State of Science and Law After the Supreme Court’s ‘Chiles’ Ruling

Wednesday, May 27th, 2:00–3:00 PM ET on Zoom

This event is free and open to the public

The recent Supreme Court ruling (Chiles v. Salazar) has huge implications for mental health professionals, but few fully grasp them. Many therapists understand the ruling as using free speech grounds to protect their right to explore patients’ gender dysphoria without being legally required to support medical or social transition—but there are important legal nuances that complicate this picture. At the same time, the ruling raises questions about ongoing professional risks: civil liability, professional sanctions, and the regulations that still govern psychotherapy. And even once the legal framework is clarified, many therapists remain uncertain about the current state of the scientific evidence surrounding treatment approaches for gender dysphoria.

This colloquium will include remarks by Ilya Shapiro and Colin Wright, followed by a brief panel discussion and an extended Q&A with attendees.

REGISTER
REGISTER

About the Panelists

  • Andrew Hartz, Ph.D.

    Andrew Hartz is a clinical psychologist and the founder and president of the Open Therapy Institute. He’s written about political issues and mental health for outlets such as the Wall Street Journal, City Journal, and the New York Post.

  • Ilya Shapiro, JD

    Ilya Shapiro is the Director of Constitutional Studies at the Manhattan Institute. He has written extensively on the Supreme Court and the First Amendment, filed over 500 amicus briefs before the Court, and previously served as executive director at Georgetown Law’s Center for the Constitution. He is the author of Lawless: The Miseducation of America’s Elites, which examines the ideological shaping of America’s governing class.

  • Colin Wright, Ph.D.

    Colin Wright is an evolutionary biologist and fellow at the Manhattan Institute, as well as an academic advisor to the Society for Evidence-Based Gender Medicine. His work focuses on the biology of sex and gender, and his writing has appeared in major outlets including the Wall Street Journal and Newsweek.